In a groundbreaking study, researchers from the HUN-REN Centre for Ecological Research have developed a novel three-dimensional modeling method that accurately quantifies how microalgae affect underwater light conditions—one of the most critical factors in aquatic ecosystem health.

Education, body mass index (BMI), and hypertension play a role in the spread of tau tangles, a hallmark of Alzheimer’s disease, according to longitudinal PET imaging data presented at the 2025 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. For patients, timely modification of these risk factors could slow down disease progression.

This study published in Engineering offers new insights into the impact of alcoholic liver disease (ALD) on post-transplant outcomes in patients with hepatocellular carcinoma (HCC) and hepatitis B virus (HBV) infection. Researchers found that ALD significantly increases the risk of HBV reactivation and worsens survival outcomes following liver transplantation. Using advanced machine learning techniques, the study identified key metabolic factors associated with HBV reactivation and developed a novel risk stratification index to better predict patient outcomes. The findings highlight the importance of considering ALD in the management of liver transplant recipients with HBV-related HCC.

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) discovered a new and potentially revolutionary way to treat glioblastoma (GBM), the most aggressive type of brain cancer with no curative treatment options. An innovative study – led by Paul B. Fisher, MPh, Ph.D., FNAI, and Swadesh K. Das, Ph.D., and recently published in the Journal for ImmunoTherapy of Cancer – created a novel molecule that demonstrated the capability to introduce a combination of treatment outcomes – direct toxicity and immunotoxicity – to kill the tumor while exploiting immunotherapy to potentially prevent the recurrence of GBM via a “Fusion Superkine” (FSK), containing dual acting therapeutic cytokines in a single molecule.

Opioids like fentanyl, morphine and oxycodone are the drugs most linked to overdoses in the U.S. Typical screening methods for drug usage involve collection of blood, saliva or urine samples. Now, in ACS’ Analytical Chemistry, researchers demonstrate a pen-like tool that can quickly and non-invasively collect molecules from the skin’s surface to be screened for opioids with mass spectrometry.

BUFFALO, NY – June 24, 2025 – A new precision oncology paper was published in Volume 16 of Oncotarget on June 17, 2025, titled “Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment.”